🇺🇸 FDA
Pipeline program

AST-OPC1

AST-OPC1-01

Phase 2 mab completed

Quick answer

AST-OPC1 for Cervical Spinal Cord Injury is a Phase 2 program (mab) at Lineage Cell Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Lineage Cell Therapeutics
Indication
Cervical Spinal Cord Injury
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials